Cardiovascular outcomes and tumour necrosis factor antagonists in chronic inflammatory rheumatic disease: a focus on rheumatoid arthritis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiovascular outcomes and tumour necrosis factor antagonists in chronic inflammatory rheumatic disease: a focus on rheumatoid arthritis
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 15, Issue sup1, Pages 55-61
Publisher
Informa UK Limited
Online
2016-12-07
DOI
10.1080/14740338.2016.1218469
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease
- (2015) Elena Myasoedova et al. ANNALS OF THE RHEUMATIC DISEASES
- Disease Activity in Rheumatoid Arthritis and the Risk of Cardiovascular Events
- (2015) D. H. Solomon et al. Arthritis & Rheumatology
- Effects of Biologic Agents and Other Disease-Modifying Antirheumatic Drugs on Cardiovascular Outcomes in Psoriasis and Psoriatic Arthritis: A Systematic Review
- (2014) April Armstrong et al. CURRENT PHARMACEUTICAL DESIGN
- Cardiovascular Risk in Rheumatoid Arthritis: Comparing TNF-α Blockade with Nonbiologic DMARDs
- (2013) Daniel H. Solomon et al. AMERICAN JOURNAL OF MEDICINE
- Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendations
- (2013) Jette Primdahl et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
- (2013) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Cardiovascular risk and inflammatory rheumatic diseases
- (2013) A. Alhusain et al. CLINICAL MEDICINE
- Cardiovascular effects of tumour necrosis factor α antagonism in patients with acute myocardial infarction: a first in human study
- (2013) Gareth J Padfield et al. HEART
- Treatment of rheumatoid arthritis with etanercept with reference to disease-modifying anti-rheumatic drugs: long-term safety and survival using prospective, observational data
- (2013) C. L. Morgan et al. RHEUMATOLOGY
- Leucocytoclastic vasculitis associated with golimumab
- (2013) Anna Pàmies et al. RHEUMATOLOGY
- Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients
- (2013) Soken-Nakazawa J Song et al. ARTHRITIS RESEARCH & THERAPY
- Heart failure risk among patients with rheumatoid arthritis starting a TNF antagonist
- (2012) Daniel H Solomon et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti-TNFα therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a Pilot Study
- (2012) Aamer Sandoo et al. BMC MUSCULOSKELETAL DISORDERS
- The Effects of Tumor Necrosis Factor Inhibitors on Cardiovascular Risk in Rheumatoid Arthritis
- (2012) Mike J.L. Peters et al. CURRENT PHARMACEUTICAL DESIGN
- Excess Cardiovascular Risk in Inflammatory Rheumatic Diseases: Pathophysiology and Targeted Therapy
- (2012) Haner Direskeneli CURRENT PHARMACEUTICAL DESIGN
- Potential Effect of Anti-Inflammatory Treatment on Reducing the Cardiovascular Risk in Rheumatoid Arthritis
- (2012) Cecilia Chighizola et al. Current Vascular Pharmacology
- Two cases of Takayasu's arteritis occurring under anti-TNF therapy
- (2012) Nicola Mariani et al. JOINT BONE SPINE
- Vasculitis Associated With Tumor Necrosis Factor-α Inhibitors
- (2012) Olayemi Sokumbi et al. MAYO CLINIC PROCEEDINGS
- Anti-TNF-Alpha-Adalimumab Therapy Is Associated with Persistent Improvement of Endothelial Function without Progression of Carotid Intima-Media Wall Thickness in Patients with Rheumatoid Arthritis Refractory to Conventional Therapy
- (2012) Carlos Gonzalez-Juanatey et al. MEDIATORS OF INFLAMMATION
- Pharmacological Undertreatment of Coronary Risk Factors in Patients with Psoriasis: Observational Study of the Danish Nationwide Registries
- (2012) Ole Ahlehoff et al. PLoS One
- Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance
- (2012) Ilias Stagakis et al. ARTHRITIS RESEARCH & THERAPY
- Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register
- (2011) R. Davies et al. ANNALS OF THE RHEUMATIC DISEASES
- Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis
- (2011) Alexa B. Kimball et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Cardiovascular safety of biologic therapies for the treatment of RA
- (2011) Jeffrey D. Greenberg et al. Nature Reviews Rheumatology
- Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis
- (2010) J. D. Greenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases
- (2010) Fabiola Atzeni et al. AUTOIMMUNITY REVIEWS
- Potential Effect of Anti-Tumour Necrosis Factor-Alpha Treatment on Reducing the Cardiovascular Risk Related to Rheumatoid Arthritis
- (2010) Massimo Cugno et al. Current Vascular Pharmacology
- Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
- (2010) S. L. Westlake et al. RHEUMATOLOGY
- Tumor necrosis factor-α blockade, cardiovascular outcomes, and survival in rheumatoid arthritis
- (2010) Ziyad Al-Aly et al. Translational Research
- Systematic review and meta-analysis: Anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis
- (2010) Cheryl Barnabe et al. ARTHRITIS CARE & RESEARCH
- EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
- (2009) M J L Peters et al. ANNALS OF THE RHEUMATIC DISEASES
- Role for TNF in atherosclerosis? Lessons from autoimmune disease
- (2009) Gayle E. McKellar et al. Nature Reviews Cardiology
- Vascular effects of biologic agents in RA and spondyloarthropathies
- (2009) Zoltán Szekanecz et al. Nature Reviews Rheumatology
- Tumor necrosis factor-α antagonist use and heart failure in elderly patients with rheumatoid arthritis
- (2008) Soko Setoguchi et al. AMERICAN HEART JOURNAL
- Does tumor necrosis factor α inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
- (2008) Joachim Listing et al. ARTHRITIS AND RHEUMATISM
- Biologics and heart failure in rheumatoid arthritis: are we any wiser?
- (2008) Maria I Danila et al. CURRENT OPINION IN RHEUMATOLOGY
- Impact of Traditional Therapies and Biologics on Cardiovascular Diseases in Rheumatoid Arthritis
- (2008) Jean-Frederic Boyer et al. Current Vascular Pharmacology
- Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs
- (2008) J Avouac et al. EXPERT OPINION ON PHARMACOTHERAPY
- Rheumatologists, take heart! We may be doing something right
- (2008) Ronald F van Vollenhoven ARTHRITIS RESEARCH & THERAPY
- Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study
- (2008) Antonio Naranjo et al. ARTHRITIS RESEARCH & THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started